XML 17 R4.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
3 Months Ended
Dec. 31, 2024
Dec. 31, 2023
OPERATING EXPENSES    
Research and development $ 5,474,147 $ 5,376,764
General and administration 4,210,719 2,217,868
Total operating expenses (9,684,866) (7,594,632)
Foreign exchange 6,402 (8,479)
Investment and other income 1,146,533 1,638,789
Net loss for the period (8,531,931) (5,964,322)
OTHER COMPREHENSIVE INCOME    
Unrealized (loss) gain on short-term investments (Note 4) (8,766) 20,124
Loss and comprehensive loss for the period $ (8,540,697) $ (5,944,198)
Loss Per Common Share    
Basic loss per common share (in dollars per share) $ (0.19) $ (0.14)
Weighted average number of common shares outstanding - Basic (in shares) 44,388,550 44,129,491